Gabapentin augmentation for fluoxetine-treated patients with obsessive-compulsive disorder

被引:40
作者
Cora-Locatelli, G
Greenberg, BD
Martin, J
Murphy, DL
机构
关键词
D O I
10.4088/JCP.v59n0907d
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
引用
收藏
页码:480 / 481
页数:2
相关论文
共 6 条
[1]  
COVINGTON EC, 1997, 150 ANN M AM PSYCH A, P195
[2]   PYRAMIDAL CELLS IN PIRIFORM CORTEX RECEIVE A CONVERGENCE OF INPUTS FROM MONOAMINE ACTIVATED GABAERGIC INTERNEURONS [J].
GELLMAN, RL ;
AGHAJANIAN, GK .
BRAIN RESEARCH, 1993, 600 (01) :63-73
[3]   GABAPENTIN - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL POTENTIAL IN EPILEPSY [J].
GOA, KL ;
SORKIN, EM .
DRUGS, 1993, 46 (03) :409-427
[4]  
KUMARAN TS, 1997, 150 ANN M AM PSYCH A, V130, P101
[5]   HYPOMANIA INDUCED BY GABAPENTIN [J].
SHORT, C ;
COOKE, L .
BRITISH JOURNAL OF PSYCHIATRY, 1995, 166 :679-680
[6]   The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-Serine [J].
Singh, L ;
Field, MJ ;
Ferris, P ;
Hunter, JC ;
Oles, RJ ;
Williams, RG ;
Woodruff, GN .
PSYCHOPHARMACOLOGY, 1996, 127 (01) :1-9